세계의 유세포 분석 시장 : 구성 요소별, 기술별, 용도별, 최종 사용자별 기회 분석 및 산업 예측(2023-2032년)

Flow Cytometry Market By Component, By Technology, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

US $ 5,820 ￦ 8,220,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 9,870 ￦ 13,941,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

유세포 분석(Flow Cytometry) 시장은 2022년에는 62억 1,642만 달러로 평가되었고, 2032년에는 165억 7,798만 달러에 이를 것으로 예측되며, 2023년부터 2032년까지의 CAGR은 10.3%로 추이하며 성장할 것으로 예상됩니다.

유세포 분석은 불균일한 혼합물에서 개별 세포와 입자의 특성을 분석하고 정량화하는 데 사용되는 강력한 기술입니다. 유세포 분석은 세포를 가늘고 좁은 유체로 통과시키고 레이저 빔을 일렬로 통과시키는 원리를 기반으로합니다. 세포는 레이저 빔을 통과할 때 산란되어 형광을 내고 검출기에 의해 수집됩니다. 유세포 분석기는 세포 크기, 형상, 입자 크기, 형광 마커로 태그가 지정된 특정 단백질과 분자의 존재 등 각 세포의 다양한 매개 변수를 측정할 수 있습니다. 이 정보는 세포 집단의 다차원 프로파일을 생성하기 위해 처리되며 세포의 구성, 건강 상태 및 기능에 대한 귀중한 통찰력을 제공합니다. 유세포 분석 시장 성장을 가속하는 주요 요인은 유세포 분석기의 기술적 진보, 다양한 연구 및 진단 응용 분야에서 유세포 분석 기술의 높은 채택을 포함합니다.

유세포 분석기의 기술적 진보는 유세포 분석 시장의 주요 촉진 요인으로 부상하고 있으며,이 강력한 분석 기술의 기능과 응용에 혁명을 일으키고 있습니다. 유세포 분석법은 불균일한 샘플에서 수천 개의 개별 세포와 입자를 신속하게 분석할 수 있게 해주며, 최근 몇 년동안 진행되는 기술 혁신으로부터 큰 혜택을 누리고 있습니다. 형광 이미징 및 이미지 기반 분석에서 기술의 발전은 연구자와 임상의가 액체 샘플에서 세포와 입자를 분석하는 방법에 혁명을 가져왔습니다.

형광 이미징은 형광 마커로 태그가 지정된 세포와 입자를 시각화하는 기술로 유세포 분석의 정확성과 감도를 크게 향상 시켰습니다. 이 기술은 개별 세포에서 여러 매개 변수의 동시 측정을 허용하고 세포의 구조와 기능에 대한 자세한 통찰력을 제공합니다. 예를 들어, 2022년 1월, 세계 의료기술 기업인 Becton, Dickinson and Company는 유럽 분자 생물학 연구소와 공동으로 연구를 실시했다고 발표했습니다. 이 연구는 형광 이미징과 이미지 기반 분석을 추가하고 바이오 마커의 유형과 양뿐만 아니라 각 세포의 시각적 세부 사항을 기반으로 개별 세포를 매우 빠르게 분류하는 유세포 분석에서 BD의 새로운 기술이 평가되었습니다. 이 신기술은 면역학, 세포 생물학, 유전체학 연구를 일변시키고, 세포를 이용한 새로운 치료법의 발견을 가능하게 할 가능성을 가지고 있습니다. 따라서 유세포 분석 기술의 기술적 진보는 시장 성장을 가속할 것으로 기대됩니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장 정의 및 범위
• 주요 조사 결과
  • 영향 요인
  • 주요 투자 기회
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진 요인
    • 기술 진보
    • 질병 진단에서 유세포 분석 기술의 높은 채택률
    • 의약품 및 약물 개발에서 유세포 분석 기술 채택의 급증
  • 억제 요인
    • 장치의 고비용
  • 기회
    • 유세포 분석에서 AI의 통합

제4장 유세포 분석 시장 : 구성 요소별

• 개요
• 장치
  • 장치 유세포 분석 시장 : 유형별
    • 플랫폼형 유세포 분석 시장 : 유형별
    • 교환 가능 컴포넌트 유세포 분석 시장 : 유형별
• 시약·소모품
  • 시약·소모품 유세포 분석 시장 : 유형별
• 소프트웨어
• 서비스

제5장 유세포 분석 시장 : 기술별

• 개요
• 셀 기반 유세포 분석
• 비드 기반 유세포 분석

제6장 유세포 분석 시장 : 용도별

• 개요
• 학술용도·임상용도
  • 학술용도·임상용도 유세포 분석 시장 : 유형별
• 진단 용도
  • 진단 용도 유세포 분석 시장 : 유형별

제7장 유세포 분석 시장 : 최종 사용자별

• 개요
• 병원
• 의학부·임상 검사 연구소
• 영리단체
• 학술기관
• 기타

제8장 유세포 분석 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아 태평양
  • 일본
  • 중국
  • 호주
  • 인도
  • 한국
  • 기타
• 남미, 중동 및 아프리카
  • 브라질
  • 사우디아라비아
  • 남아프리카공화국
  • 기타

제9장 경쟁 구도

• 소개
• 주요 성공 전략
• 주요 10개사의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2022년)

제10장 기업 개요

• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• BioMerieux SA
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Miltenyi Biotec GmbH.
• Sartorius AG
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Cytek Biosciences

LYJ

영문 목차

영문목차

The Flow Cytometry Market was valued at $6,216.42 million in 2022 and is estimated to reach $16,577.98 million by 2032, exhibiting a CAGR of 10.3% from 2023 to 2032. Flow cytometry is a powerful technique used to analyze and quantify the characteristics of individual cells or particles in a heterogeneous mixture. It operates on the principle of passing cells through a narrow, focused stream of fluid, allowing them to pass single file through a laser beam. As cells pass through the laser beam, they scatter and emit fluorescent light, which is collected by detectors. Flow cytometers can measure various parameters of each cell, including size, shape, granularity, and the presence of specific proteins or molecules tagged with fluorescent markers. This information is then processed to create a multi-dimensional profile of the cell population, providing valuable insights into cell composition, health, and function. Major factors that drive growth of the flow cytometry market include technological advancements in the flow cytometry and high adoption of flow cytometry techniques in various research and diagnostic applications.

Technological advancements in flow cytometry have emerged as a major driver in the flow cytometry market, revolutionizing the capabilities and applications of this powerful analytical technique. Flow cytometry, which allows for the rapid analysis of thousands of individual cells or particles in a heterogeneous sample, has benefited greatly from ongoing innovations in recent years. Technological advancements in fluorescence imaging and image-based analysis have revolutionized the way researchers and clinicians analyze cells and particles in fluid samples.

Fluorescence imaging, a technique that allows the visualization of cells and particles tagged with fluorescent markers, has greatly enhanced the precision and sensitivity of flow cytometry. This technology enables the simultaneous measurement of multiple parameters within individual cells, providing detailed insights into cell structure and function. For instance, in January 2022, Becton, Dickinson and Company, a global medical technology company, announced that a study was conducted in collaboration with the European Molecular Biology Laboratory. The study evaluated new BD innovation in flow cytometry that adds fluorescence imaging and image-based analysis to sort individual cells at exceptionally high speed, based on the visual details of each cell and not solely on the type or quantity of biomarkers that are present. The new technology has the potential to transform immunology, cell biology and genomics research and enable new cell-based therapeutic discovery. Thus, the technological advancement in the flow cytometry technology is expected to drive the growth of the market.

In addition, the high adoption of flow cytometry techniques has emerged as a major driving force in the growth of the flow cytometry market, owing to its widespread utilization in diverse research and diagnostic applications. Flow cytometry, a powerful analytical tool, has gained immense popularity in the scientific community due to its ability to simultaneously analyze multiple properties of individual cells or particles at a rapid pace. In research, it has become indispensable for studying cell biology, immunology, and cancer research, allowing scientists to analyze cell populations, sort specific cell types, and assess various cellular characteristics such as size, shape, and molecular markers. Flow cytometry has also revolutionized the field of clinical diagnostics. In the realm of clinical medicine, it plays a pivotal role in the diagnosis and monitoring of various diseases, including hematological malignancies, immunodeficiency disorders, and HIV. The ability to analyze and quantify specific biomarkers on individual cells has made flow cytometry an invaluable tool for clinical laboratories. For instance, according to a 2022 report by the National Library of Medicine, flow cytometry analysis plays a critical role in the diagnosis of leukemias and other hematolymphoid malignancies. Flow cytometry can quickly identify the abnormal cell population, characterize its phenotype, give lineage classification, make the diagnosis, or narrow down the differential list. Thus, the high adoption of flow cytometry technique in various research and diagnostic applications is expected to drive the growth of the market.

However, factors such as high cost associated with instruments and reagents, lack of awareness among potential end users, and limited availability of technical expertise are expected to hamper the market growth. Moreover, preference of flow cytometry in drug discovery & development and diagnostics is expected to provide numerous growth opportunities.

The flow cytometry market is segmented on the basis of component, technology, application, end user, and region. By component, the flow cytometry market is segmented into instruments, reagents & consumables, software, and services. The instrument segment is further divided into platforms and replaceable components. The platforms segment is further categorized into sorters and analyzers. Filters, lasers, detectors, and others are considered as types of replaceable components. The reagents market is further divided into antibodies, dyes, beads, and others.

On the basis of technology, the market is segmented into cell-based flow cytometry and bead-based flow cytometry. As per application, it is segmented into academic & clinical applications and diagnostic applications. The academic & clinical applications segment is further divided into cell cycle analysis & cell proliferation, apoptosis, cell sorting, transfect ion & cell viability, and others.

The diagnostic applications segment is further segmented into organ transplantation, hematological malignancies, HIV, solid tumors & cancer, and others. On the basis of end user, the market is categorized into hospitals, medical schools & clinical testing labs, commercial organizations, academic institutions, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global flow cytometry market are Agilent Technologies, Inc., Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, DiaSorin S.p.A. (Luminex Corporation), Miltenyi Biotec, Inc., Sartorius AG, Sysmex Corporation, and Thermo Fisher Scientific Inc.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the flow cytometry market analysis from 2022 to 2032 to identify the prevailing flow cytometry market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the flow cytometry market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global flow cytometry market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Market share analysis of players by products/segments
• New Product Development/ Product Matrix of Key Players
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Average Selling Price Analysis / Price Point Analysis
• Expanded list for Company Profiles
• Historic market data
• SWOT Analysis

Key Market Segments

By Component

• Instruments
  • Type
  • Platform

Type

• Replaceable component

Type

• Reagents and consumables
  • Type
  • Antibodies
  • Dyes
  • Beads
  • Others
• Software
• Services

By Technology

• Cell based flow cytometry
• Bead based flow cytometry

By Application

• Academic and clinical applications
  • Type
  • Cell Cycle Analysis and Cell Proliferation
  • Apoptosis
  • Cell Sorting
  • Transfect Ion and Cell Viability
  • Others
• Diagnostic applications
  • Type
  • Organ Transplantation
  • Hematological Malignancies
  • HIV
  • Solid Tumors and Cancer
  • Others

By End User

• Hospitals
• Medical schools and clinical testing labs
• Commercial organizations
• Academic institutions
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Bio-Rad Laboratories, Inc.
• Miltenyi Biotec GmbH.
• Sartorius AG
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Thermo Fisher Scientific Inc.
• Sysmex Corporation
• Danaher Corporation
• Cytek Biosciences
• BioMerieux SA

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Low bargaining power of suppliers
  • 3.3.2. Low threat of new entrants
  • 3.3.3. Low threat of substitutes
  • 3.3.4. Low intensity of rivalry
  • 3.3.5. Low bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Technological advancements
    • 3.4.1.2. High adoption of flow cytometry technique in disease diagnosis
    • 3.4.1.3. Surge in adoption of flow cytometry technique in drug discovery and development.
  • 3.4.2. Restraints
    • 3.4.2.1. High cost of instrument
  • 3.4.3. Opportunities
    • 3.4.3.1. Integration of AI in flow cytometry

CHAPTER 4: FLOW CYTOMETRY MARKET, BY COMPONENT

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Instruments
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
  • 4.2.4. Instruments Flow Cytometry Market by Type
    • 4.2.4.1. Platform Flow Cytometry Market by Type
    • 4.2.4.2. Replaceable component Flow Cytometry Market by Type
• 4.3. Reagents and consumables
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
  • 4.3.4. Reagents and consumables Flow Cytometry Market by Type
• 4.4. Software
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country
• 4.5. Services
  • 4.5.1. Key market trends, growth factors and opportunities
  • 4.5.2. Market size and forecast, by region
  • 4.5.3. Market share analysis by country

CHAPTER 5: FLOW CYTOMETRY MARKET, BY TECHNOLOGY

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Cell based flow cytometry
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Bead based flow cytometry
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country

CHAPTER 6: FLOW CYTOMETRY MARKET, BY APPLICATION

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Academic and clinical applications
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
  • 6.2.4. Academic and clinical applications Flow Cytometry Market by Type
• 6.3. Diagnostic applications
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
  • 6.3.4. Diagnostic applications Flow Cytometry Market by Type

CHAPTER 7: FLOW CYTOMETRY MARKET, BY END USER

• 7.1. Overview
  • 7.1.1. Market size and forecast
• 7.2. Hospitals
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by region
  • 7.2.3. Market share analysis by country
• 7.3. Medical schools and clinical testing labs
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by region
  • 7.3.3. Market share analysis by country
• 7.4. Commercial organizations
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by region
  • 7.4.3. Market share analysis by country
• 7.5. Academic institutions
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by region
  • 7.5.3. Market share analysis by country
• 7.6. Others
  • 7.6.1. Key market trends, growth factors and opportunities
  • 7.6.2. Market size and forecast, by region
  • 7.6.3. Market share analysis by country

CHAPTER 8: FLOW CYTOMETRY MARKET, BY REGION

• 8.1. Overview
  • 8.1.1. Market size and forecast By Region
• 8.2. North America
  • 8.2.1. Key market trends, growth factors and opportunities
  • 8.2.2. Market size and forecast, by Component
  • 8.2.3. Market size and forecast, by Technology
  • 8.2.4. Market size and forecast, by Application
  • 8.2.5. Market size and forecast, by End User
  • 8.2.6. Market size and forecast, by country
    • 8.2.6.1. U.S.
    • 8.2.6.1.1. Market size and forecast, by Component
    • 8.2.6.1.2. Market size and forecast, by Technology
    • 8.2.6.1.3. Market size and forecast, by Application
    • 8.2.6.1.4. Market size and forecast, by End User
    • 8.2.6.2. Canada
    • 8.2.6.2.1. Market size and forecast, by Component
    • 8.2.6.2.2. Market size and forecast, by Technology
    • 8.2.6.2.3. Market size and forecast, by Application
    • 8.2.6.2.4. Market size and forecast, by End User
    • 8.2.6.3. Mexico
    • 8.2.6.3.1. Market size and forecast, by Component
    • 8.2.6.3.2. Market size and forecast, by Technology
    • 8.2.6.3.3. Market size and forecast, by Application
    • 8.2.6.3.4. Market size and forecast, by End User
• 8.3. Europe
  • 8.3.1. Key market trends, growth factors and opportunities
  • 8.3.2. Market size and forecast, by Component
  • 8.3.3. Market size and forecast, by Technology
  • 8.3.4. Market size and forecast, by Application
  • 8.3.5. Market size and forecast, by End User
  • 8.3.6. Market size and forecast, by country
    • 8.3.6.1. Germany
    • 8.3.6.1.1. Market size and forecast, by Component
    • 8.3.6.1.2. Market size and forecast, by Technology
    • 8.3.6.1.3. Market size and forecast, by Application
    • 8.3.6.1.4. Market size and forecast, by End User
    • 8.3.6.2. France
    • 8.3.6.2.1. Market size and forecast, by Component
    • 8.3.6.2.2. Market size and forecast, by Technology
    • 8.3.6.2.3. Market size and forecast, by Application
    • 8.3.6.2.4. Market size and forecast, by End User
    • 8.3.6.3. UK
    • 8.3.6.3.1. Market size and forecast, by Component
    • 8.3.6.3.2. Market size and forecast, by Technology
    • 8.3.6.3.3. Market size and forecast, by Application
    • 8.3.6.3.4. Market size and forecast, by End User
    • 8.3.6.4. Italy
    • 8.3.6.4.1. Market size and forecast, by Component
    • 8.3.6.4.2. Market size and forecast, by Technology
    • 8.3.6.4.3. Market size and forecast, by Application
    • 8.3.6.4.4. Market size and forecast, by End User
    • 8.3.6.5. Spain
    • 8.3.6.5.1. Market size and forecast, by Component
    • 8.3.6.5.2. Market size and forecast, by Technology
    • 8.3.6.5.3. Market size and forecast, by Application
    • 8.3.6.5.4. Market size and forecast, by End User
    • 8.3.6.6. Rest of Europe
    • 8.3.6.6.1. Market size and forecast, by Component
    • 8.3.6.6.2. Market size and forecast, by Technology
    • 8.3.6.6.3. Market size and forecast, by Application
    • 8.3.6.6.4. Market size and forecast, by End User
• 8.4. Asia-Pacific
  • 8.4.1. Key market trends, growth factors and opportunities
  • 8.4.2. Market size and forecast, by Component
  • 8.4.3. Market size and forecast, by Technology
  • 8.4.4. Market size and forecast, by Application
  • 8.4.5. Market size and forecast, by End User
  • 8.4.6. Market size and forecast, by country
    • 8.4.6.1. Japan
    • 8.4.6.1.1. Market size and forecast, by Component
    • 8.4.6.1.2. Market size and forecast, by Technology
    • 8.4.6.1.3. Market size and forecast, by Application
    • 8.4.6.1.4. Market size and forecast, by End User
    • 8.4.6.2. China
    • 8.4.6.2.1. Market size and forecast, by Component
    • 8.4.6.2.2. Market size and forecast, by Technology
    • 8.4.6.2.3. Market size and forecast, by Application
    • 8.4.6.2.4. Market size and forecast, by End User
    • 8.4.6.3. Australia
    • 8.4.6.3.1. Market size and forecast, by Component
    • 8.4.6.3.2. Market size and forecast, by Technology
    • 8.4.6.3.3. Market size and forecast, by Application
    • 8.4.6.3.4. Market size and forecast, by End User
    • 8.4.6.4. India
    • 8.4.6.4.1. Market size and forecast, by Component
    • 8.4.6.4.2. Market size and forecast, by Technology
    • 8.4.6.4.3. Market size and forecast, by Application
    • 8.4.6.4.4. Market size and forecast, by End User
    • 8.4.6.5. South Korea
    • 8.4.6.5.1. Market size and forecast, by Component
    • 8.4.6.5.2. Market size and forecast, by Technology
    • 8.4.6.5.3. Market size and forecast, by Application
    • 8.4.6.5.4. Market size and forecast, by End User
    • 8.4.6.6. Rest of Asia-Pacific
    • 8.4.6.6.1. Market size and forecast, by Component
    • 8.4.6.6.2. Market size and forecast, by Technology
    • 8.4.6.6.3. Market size and forecast, by Application
    • 8.4.6.6.4. Market size and forecast, by End User
• 8.5. LAMEA
  • 8.5.1. Key market trends, growth factors and opportunities
  • 8.5.2. Market size and forecast, by Component
  • 8.5.3. Market size and forecast, by Technology
  • 8.5.4. Market size and forecast, by Application
  • 8.5.5. Market size and forecast, by End User
  • 8.5.6. Market size and forecast, by country
    • 8.5.6.1. Brazil
    • 8.5.6.1.1. Market size and forecast, by Component
    • 8.5.6.1.2. Market size and forecast, by Technology
    • 8.5.6.1.3. Market size and forecast, by Application
    • 8.5.6.1.4. Market size and forecast, by End User
    • 8.5.6.2. Saudi Arabia
    • 8.5.6.2.1. Market size and forecast, by Component
    • 8.5.6.2.2. Market size and forecast, by Technology
    • 8.5.6.2.3. Market size and forecast, by Application
    • 8.5.6.2.4. Market size and forecast, by End User
    • 8.5.6.3. South Africa
    • 8.5.6.3.1. Market size and forecast, by Component
    • 8.5.6.3.2. Market size and forecast, by Technology
    • 8.5.6.3.3. Market size and forecast, by Application
    • 8.5.6.3.4. Market size and forecast, by End User
    • 8.5.6.4. Rest of LAMEA
    • 8.5.6.4.1. Market size and forecast, by Component
    • 8.5.6.4.2. Market size and forecast, by Technology
    • 8.5.6.4.3. Market size and forecast, by Application
    • 8.5.6.4.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

• 9.1. Introduction
• 9.2. Top winning strategies
• 9.3. Product mapping of top 10 player
• 9.4. Competitive dashboard
• 9.5. Competitive heatmap
• 9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

• 10.1. Agilent Technologies, Inc.
  • 10.1.1. Company overview
  • 10.1.2. Key executives
  • 10.1.3. Company snapshot
  • 10.1.4. Operating business segments
  • 10.1.5. Product portfolio
  • 10.1.6. Business performance
  • 10.1.7. Key strategic moves and developments
• 10.2. Becton, Dickinson and Company
  • 10.2.1. Company overview
  • 10.2.2. Key executives
  • 10.2.3. Company snapshot
  • 10.2.4. Operating business segments
  • 10.2.5. Product portfolio
  • 10.2.6. Business performance
  • 10.2.7. Key strategic moves and developments
• 10.3. BioMerieux SA
  • 10.3.1. Company overview
  • 10.3.2. Key executives
  • 10.3.3. Company snapshot
  • 10.3.4. Operating business segments
  • 10.3.5. Product portfolio
  • 10.3.6. Business performance
• 10.4. Bio-Rad Laboratories, Inc.
  • 10.4.1. Company overview
  • 10.4.2. Key executives
  • 10.4.3. Company snapshot
  • 10.4.4. Operating business segments
  • 10.4.5. Product portfolio
  • 10.4.6. Business performance
  • 10.4.7. Key strategic moves and developments
• 10.5. Danaher Corporation
  • 10.5.1. Company overview
  • 10.5.2. Key executives
  • 10.5.3. Company snapshot
  • 10.5.4. Operating business segments
  • 10.5.5. Product portfolio
  • 10.5.6. Business performance
  • 10.5.7. Key strategic moves and developments
• 10.6. Miltenyi Biotec GmbH.
  • 10.6.1. Company overview
  • 10.6.2. Key executives
  • 10.6.3. Company snapshot
  • 10.6.4. Operating business segments
  • 10.6.5. Product portfolio
• 10.7. Sartorius AG
  • 10.7.1. Company overview
  • 10.7.2. Key executives
  • 10.7.3. Company snapshot
  • 10.7.4. Operating business segments
  • 10.7.5. Product portfolio
  • 10.7.6. Business performance
• 10.8. Sysmex Corporation
  • 10.8.1. Company overview
  • 10.8.2. Key executives
  • 10.8.3. Company snapshot
  • 10.8.4. Operating business segments
  • 10.8.5. Product portfolio
  • 10.8.6. Business performance
  • 10.8.7. Key strategic moves and developments
• 10.9. Thermo Fisher Scientific Inc.
  • 10.9.1. Company overview
  • 10.9.2. Key executives
  • 10.9.3. Company snapshot
  • 10.9.4. Operating business segments
  • 10.9.5. Product portfolio
  • 10.9.6. Business performance
  • 10.9.7. Key strategic moves and developments
• 10.10. Cytek Biosciences
  • 10.10.1. Company overview
  • 10.10.2. Key executives
  • 10.10.3. Company snapshot
  • 10.10.4. Operating business segments
  • 10.10.5. Product portfolio

관련자료